Emergency Medicine

OASIS-5

Study

OAT

Study

OCEAN(a)-DOSE (olpasiran 10 mg)

Study

OCEAN(a)-DOSE (olpasiran 225 mg every 12 weeks)

Study

OCEAN(a)-DOSE (olpasiran 225 mg every 24 weeks)

Study

OCEAN(a)-DOSE (olpasiran 75 mg)

Study

OCEANIC-AF

Study

OCTIVUS

Study

OCTOBER

Study

Octreotide

Drug

ODYSSEY OUTCOMES

Study

Olanzapine

Drug

Omeprazole for peptic ulcer bleeding

Study

ONCO PE

Study

Ondansetron

Drug

Ondansetron hydrochloride

Drug

ONTARGET (telmisartan with ramipril)

Study

ONTARGET (telmisartan)

Study

Opioid use disorder

Disease

OPT-BIRISK

Study

OPTIMAL-BP

Study

OPTIMAS

Study

OPTION

Study

OptiTHO

Study

ORBITA-2

Study

ORIGINAL

Study

OT-PVCs

Study

OUtMATCH

Study

Oxy-PICU

Study